洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2600127128】Effects of Wearing a Sauna Suit During High-Intensity Interval Exercise

基本信息
登记号

ChiCTR2600127128

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2026-06-25

临床申请受理号

/

靶点

/

适应症

No

试验通俗题目

Effects of Wearing a Sauna Suit During High-Intensity Interval Exercise

试验专业题目

The Acute Effects of HIIT While Wearing Sauna Suits on Physiological and Perceptual Responses

申办单位信息
申请人联系人
请登录查看
申请人名称

/

联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

This study aims to investigate the acute physiological and perceptual consequences of performing high-intensity interval training (HIIT) while wearing sauna suits, with a specific focus on three critical outcomes: (1) the impact on core body temperature, skin temperature, (2) the impact on perceptual responses such as thermal sensation, RPE (3) the influence on energy expenditure and metabolic rate.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

Permuted block randomization (block size = 4) was used for random sequence generation, and the random number sequence was produced by an independent researcher who was not involved in participant recruitment, data collection or experimental interventions. Allocation concealment was achieved via sequentially numbered, opaque, sealed envelopes (SNOSE).

盲法

None

试验项目经费来源

University Research Funding

试验范围

/

目标入组人数

12

实际入组人数

/

第一例入组时间

2025-02-01

试验终止时间

2025-04-30

是否属于一致性

/

入选标准

Subjects are moderately 24 active men aged between 18-24, BMI between 18-23. Subjects are moderately 24 active men aged between 18-24, BMI between 18-23.;

排除标准

Exclusion from participation included current or recent (< 6 months) smokers, and those with any past or present history of cardiovascular diseases and/or heat-related contraindications.;

研究者信息
研究负责人姓名
请登录查看
试验机构

The Chinese University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

The Chinese University of Hong Kong的其他临床试验

的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

同适应症药物临床试验